跳至主要内容
临床试验/NCT03202745
NCT03202745撤回不适用

The Effect of Informative Letters on the Prescription and Receipt of Opioids

Abdul Latif Jameel Poverty Action Lab0 个研究点开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Morphine Milligrams Equivalent (MME)

研究概览

简要总结

Inappropriate prescribing exposes patients to health risks and results in wasteful public expenditures. This study will evaluate an approach to fighting abusive prescription: sending letters to suspected potentially inappropriate prescribers warning them that they are outliers compared to their peers and have been flagged for review. The study will target high prescribers of opioids in the Schedule II controlled substances class. Two types of letters will be tested: one focusing on the health consequences of inappropriate prescribing for patients, and the other focusing on the consequences for prescribers including e.g. potential administrative actions. Using claims data, the investigators will assess the effect of the letters on prescribing of opioids, receipt of opioids by patients, substitution behavior by prescribers and patients, and health outcomes of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Outlier with respect to prescribing of Schedule II opioids relative to peers, measured in prescription drug events (PDE), in 2014Q3-2015Q2 and 2015Q3-2016Q2
  • Outlier with respect to prescribing of Schedule II opioids relative to peers, measured in 30-day equivalents, in 2014Q3-2015Q2 and 2015Q3-2016Q2

排除标准

  • Fewer than 75 Schedule II Opioid PDE in 2015Q3-2016Q2
  • Specialty listed as "Student in an Organized Health Care Education/Training Program"

结局指标

主要结局

Morphine Milligrams Equivalent (MME)

时间窗: 9 months

次要结局

未报告次要终点

研究者

发起方
Abdul Latif Jameel Poverty Action Lab
申办方类型
Other
责任方
Sponsor

相似试验